Search Results
Answer created by AI
- Like
- Disike
AI result is experimental
Generating Answer...
-
Clinical Trials (9659)
-
Therapy Area (2572)
-
Technology (2480)
-
Suvoda WP (2263)
-
Covid-19 (1663)
-
Approvals (1657)
-
Oncology (1518)
-
Infectious Disease (1392)
-
Drug Development (1348)
-
FDI (1227)
-
Genomics (1205)
-
API Manufacturers (1131)
-
Clinical Trials Arena (793)
-
COVID Cross-sector Impact Brief (530)
-
Country Risk Report Q4 2021 - Professional Services (506)
-
Oracle NAS WP (464)
-
Central Nervous System (410)
-
Neurology (361)
-
Operations (296)
No Filter Selected
-
News Analysis and Comments (17324)
-
Projects (742)
-
Press Releases (647)
-
White Papers (553)
-
Suppliers (280)
-
Supplier Products (105)
No Filter Selected
-
Clinical Trials (59)
-
Contract Research Organization (53)
-
Artificial Intelligence (14)
-
Clinical Data Management Services (13)
-
Consulting (13)
-
Cloud (12)
-
Clinical Pharmacological Services (11)
-
Clinical Trial Patient Recruitment (11)
-
Cybersecurity (11)
-
Internet of Things (11)
-
Analytical Services (10)
-
Bioavailability Studies (10)
-
Biomarker Services (10)
-
Clinical Development Services (10)
-
Clinical Trial Design Services (10)
-
Clinical Trial Monitoring (10)
-
Clinical Trial Site Selection and Management (10)
-
Contract Manufacturers (10)
-
Environmental, Social, and Governance (10)
-
Software & Technology (10)
No Filter Selected
-
United States (4786)
-
Global (1100)
-
North America (696)
-
United Kingdom (693)
-
Europe (560)
-
China (443)
-
Australia (226)
-
Asia-Pacific (213)
-
United States of America (209)
-
UK (189)
-
Switzerland (188)
-
France (181)
-
Canada (180)
-
Japan (167)
-
Germany (141)
-
India (119)
-
US (107)
-
Israel (104)
-
Russia (95)
-
Sweden (71)
No Filter Selected
-
Artificial Intelligence (7)
-
Big Data (5)
-
Biosimilars (1)
-
Blockchain (2)
-
Cell & Gene Therapy (1)
-
Cloud (4)
-
Corporate Governance (4)
-
Covid-19 (4)
-
Cybersecurity (5)
-
Digitalization (2)
-
Easy & Affordable (1)
-
Electronic Medical Record (EMR) Systems (1)
-
Environmental Sustainability (5)
-
Future of Work (3)
-
Genomics (1)
-
Health & Wellness (1)
-
Immuno-oncology (7)
-
Internet of Things (3)
-
Microbiome (2)
-
Mobile Health (1)
No Filter Selected
GlobalData Epidemiologist Report: Global Covid cases pass 26 million - Brazil and India near 4 million
3 September Globally, the total confirmed cases of Covid-19 have reached over 26,062,000, with over 863,000 deaths and 17,315,000 recoveries.…
Overall clinical trial disruption due to Covid-19 declines, but the number of trials with slow recruitment continues to grow
Since early March, around 1,000 organisations supporting clinical trials as a sponsor, collaborator, or contract research organisation (CRO) have publicly…
Sanofi and GSK begin Phase I/II trial of Covid-19 vaccine
Sanofi and GlaxoSmithKline (GSK) have initiated a Phase I/II clinical trial to evaluate their adjuvanted recombinant protein-based vaccine candidate against Covid-19.
ESC 2020: Amarin details positive Vascepa data amid looming threat for US market generic entry
On August 29, at this year’s European Society of Cardiology (ESC) conference, Amarin Corporation presented final results from the 80-patient,…
Janssen to stop clinical development of pimodivir for influenza
Janssen Pharmaceutical has decided to halt the clinical development of an experimental antiviral drug, pimodivir, to treat patients with influenza A infection.
Coronavirus in South Korea: COVID-19 outbreak, measures and impact
Neighbouring two coronavirus-affected countries China and Japan, South Korea is among the top ten countries with coronavirus cases.
China approves first anti-viral drug against coronavirus Covid-19
Anti-viral drug Favilavir has secured approval from the National Medical Products Administration of China to treat coronavirus Covid-19, according to media reports.
Favilavir approved as experimental coronavirus drug
Zhejiang Hisun Pharmaceutical’s anti-viral drug Favilavir (Favipiravir) has been approved as an investigational therapy to treat the coronavirus, reported local media.
Inovio Pharmaceuticals set to trial Covid-19 vaccine in April
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreak on our timeline.…
How healthcare investment can boost jobs
4 September The Covid-19 pandemic has highlighted the importance of having a robust healthcare system for every country across the…
International update: Global Covid cases pass 26.3 million - US gears up for early vaccine roll out
4 September Global: Global Covid-19 deaths are nearing 869,000 with more than 26.3 million cases according to the Johns Hopkins…
COVID-19 in the Middle East: Coronavirus-affected countries
Covid-19 is the second coronavirus outbreak that affects the Middle East, following the MERS-CoV reported in Saudi Arabia in 2012. United Arab Emirates (UAE) was the first Middle East country to report a coronavirus-positive case, following the Wuhan coronavirus outbreak in China.
Roche reports new data of multiple sclerosis drug Ocrevus
Roche has reported new data from analyses of the two-year open-label Phase IIIb CASTING clinical trial of Ocrevus in patients with relapsing-remitting MS (RRMS).
Akebia reports mixed results of vadadustat as anaemia treatment in CKD
Akebia Therapeutics has reported top-line data from the Phase III PRO2TECT clinical trials of vadadustat as a treatment for anaemia associated with chronic kidney disease (CKD) in adults not on dialysis.
AbbVie to test HIV drug for Covid-19 treatment
AbbVie has announced plans to evaluate HIV medicine Kaletra/Aluvia (lopinavir/ritonavir) as a treatment for Covid-19 caused by the novel coronavirus.
GlobalData Epidemiologist Report: Global Covid-19 cases pass 26.3 million - deaths exceed 869,000
4 September Globally, the total confirmed cases of Covid-19 have reached over 26,337,000, with more than 869,000 deaths and 17,545,000…
Opyl develops AI software to predict outcomes of Covid-19 trials
Australian company Opyl has developed new software that can forecast the outcomes of Covid-19 clinical trials using artificial intelligence (AI).
The state of play: FDI in Germany
Germany is a global powerhouse when it comes to attracting foreign direct investment (FDI), and its position of strength was…
Investment firm GI Partners closes Clinical Ink acquisition
Private equity investment firm GI Partners has announced the completion of the acquisition of global clinical trial technology firm Clinical Ink.
Investment firm GI Partners to acquire minority interest in Clinical Ink
Private equity investment firm GI Partners has announced that it will acquire a minority interest in global clinical trial technology Clinical Ink.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- 200
- 201
- 202
- 203
- 204
- 205
- 206
- 207
- 208
- 209
- 210
- 211
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- 219
- 220
- 221
- 222
- 223
- 224
- 225
- 226
- 227
- 228
- 229
- 230
- 231
- 232
- 233
- 234
- 235
- 236
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- 248
- 249
- 250
- 251
- 252
- 253
- 254
- 255
- 256
- 257
- 258
- 259
- 260
- 261
- 262
- 263
- 264
- 265
- 266
- 267
- 268
- 269
- 270
- 271
- 272
- 273
- 274
- 275
- 276
- 277
- 278
- 279
- 280
- 281
- 282
- 283
- 284
- 285
- 286
- 287
- 288
- 289
- 290
- 291
- 292
- 293
- 294
- 295
- 296
- 297
- 298
- 299
- 300
- 301
- 302
- 303
- 304
- 305
- 306
- 307
- 308
- 309
- 310
- 311
- 312
- 313
- 314
- 315
- 316
- 317
- 318
- 319
- 320
- 321
- 322
- 323
- 324
- 325
- 326
- 327
- 328
- 329
- 330
- 331
- 332
- 333
- 334
- 335
- 336
- 337
- 338
- 339
- 340
- 341
- 342
- 343
- 344
- 345
- 346
- 347
- 348
- 349
- 350
- 351
- 352
- 353
- 354
- 355
- 356
- 357
- 358
- 359
- 360
- 361
- 362
- 363
- 364
- 365
- 366
- 367
- 368
- 369
- 370
- 371
- 372
- 373
- 374
- 375
- 376
- 377
- 378
- 379
- 380
- 381
- 382
- 383
- 384
- 385
- 386
- 387
- 388
- 389
- 390
- 391
- 392
- 393
- 394
- 395
- 396
- 397
- 398
- 399
- 400
- 401
- 402
- 403
- 404
- 405
- 406
- 407
- 408
- 409
- 410
- 411
- 412
- 413
- 414
- 415
- 416
- 417
- 418
- 419
- 420
- 421
- 422
- 423
- 424
- 425
- 426
- 427
- 428
- 429
- 430
- 431
- 432
- 433
- 434
- 435
- 436
- 437
- 438
- 439
- 440
- 441
- 442
- 443
- 444
- 445
- 446
- 447
- 448
- 449
- 450
- 451
- 452
- 453
- 454
- 455
- 456
- 457
- 458
- 459
- 460
- 461
- 462
- 463
- 464
- 465
- 466
- 467
- 468
- 469
- 470
- 471
- 472
- 473
- 474
- 475
- 476
- 477
- 478
- 479
- 480
- 481
- 482
- 483
- 484
- 485
- 486
- 487
- 488
- 489
- 490
- 491
- 492
- 493
- 494
- 495
- 496
- 497
- 498
- 499
- 500